科研之友
微信
新浪微博
Facebook
分享链接
摘要
The treatment of depressive disorders in alcohol-dependent patients is often a difficult clinical challenge. For example, regulatory framework inhibits the access to psychotherapeutic treatment. So, the demand of a permanent abstinence is a prerequisite for the reimbursement of psychotherapeutic treatment. Contrary to those claims that are not compatible with the current state of research on the neurobiological basis of addiction, clinical studies show that combined treatment strategies including the simultaneous treatment of depression and addictive disorders lead to higher therapeutic success rates. Regarding pharmacotherapy, a combined treatment with drugs for relapse prevention and anti-depressives may be considered useful. Psychotherapeutically, a combination of motivation-enhancing approaches and cognitive-behavioral methods can be considered an effective treatment of both disorders.
- 出版日期2012
